Ofatumumab Now Has Full European Union Authorization for CLLOfatumumab Now Has Full European Union Authorization for CLL

The drug now has full European Union authorization for use in chronic lymphocytic leukemia (CLL) in combination with chlorambucil or bendamustine for patients ineligible for fludarabine-based therapy. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news